Loading…

Drug Conjugation to Cyclic Peptide-Polymer Self-Assembling Nanotubes

We show for the first time how polymeric nanotubes (NTs) based on self‐assembled conjugates of polymers and cyclic peptides can be used as an efficient drug carrier. RAPTA‐C, a ruthenium‐based anticancer drug, was conjugated to a statistical co‐polymer based on poly(2‐hydroxyethyl acrylate) (pHEA) a...

Full description

Saved in:
Bibliographic Details
Published in:Chemistry : a European journal 2014-09, Vol.20 (40), p.12745-12749
Main Authors: Blunden , Bianca M., Chapman, Robert, Danial, Maarten, Lu, Hongxu, Jolliffe, Katrina A., Perrier , Sébastien, Stenzel, Martina H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We show for the first time how polymeric nanotubes (NTs) based on self‐assembled conjugates of polymers and cyclic peptides can be used as an efficient drug carrier. RAPTA‐C, a ruthenium‐based anticancer drug, was conjugated to a statistical co‐polymer based on poly(2‐hydroxyethyl acrylate) (pHEA) and poly(2‐chloroethyl methacrylate) (pCEMA), which formed the shell of the NTs. Self‐assembly into nanotubes (length 200–500 nm) led to structures exhibiting high activity against cancer cells. Polymeric nanotubes (NTs) based on self‐assembled conjugates of polymers and cyclic peptides can be used as an efficient drug carrier for RAPTA‐C, a ruthenium‐based anticancer drug. The drug was conjugated to a water‐soluble polymer, which formed the shell of the NTs. The self‐assembled nanotubes (ca. 200–500 nm in length) had a significant activity against cancer cells (see figure).
ISSN:0947-6539
1521-3765
DOI:10.1002/chem.201403130